Butterfly Network to Present at the Cowen 6th Annual FutureHealth Conference

Rhea-AI Summary

Butterfly Network (NYSE: BFLY) announced its participation in the Cowen 6^th Annual FutureHealth Conference, a virtual event on June 16-17, 2021. Dr. Todd Fruchterman, the President and CEO, along with CFO Stephanie Fielding and CMO Dr. John Martin, will discuss 'Handheld Point-of-Care Ultrasound' on June 16 at 2:35 p.m. ET. The conversation will be available via the investor relations section of Butterfly Network's website. Butterfly, founded in 2011, aims to democratize medical imaging using its innovative Butterfly iQ system, promoting health equity for the 4.7 billion people lacking ultrasound access.

Butterfly Network (NYSE: BFLY) (“Butterfly”), an innovative digital health company that is working to democratize medical imaging and contribute to the aspiration of global health equity, today announced its participation in the Cowen 6^th Annual FutureHealth Conference, a virtual event taking place June 16-17, 2021.

Dr. Todd Fruchterman, President and CEO, Stephanie Fielding, Chief Financial Officer, and Dr. John Martin, Chief Medical Officer, will participate in a fireside chat session titled “Handheld Point-of-Care Ultrasound” at 2:35 p.m. ET on Wednesday, June 16.

A webcast of the fireside chat discussion can be accessed via the investor relations section of the Butterfly Network website at Events & Presentations.

About Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011 and recently listed on the New York Stock Exchange through a business combination with Longview Acquisition Corp., Butterfly Network created the world's only handheld, single-probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ. Its mission is to democratize medical imaging and contribute to the aspiration of global health equity by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected—including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip™ technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ can be purchased online today by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.

Butterfly iQ is a prescription device intended for trained and qualified healthcare professionals only.

For more information, visit www.butterflynetwork.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005981/en/

FAQ

What event is Butterfly Network (BFLY) participating in June 2021?

Butterfly Network is participating in the Cowen 6th Annual FutureHealth Conference on June 16-17, 2021.

Who will represent Butterfly Network at the conference?

Dr. Todd Fruchterman (CEO), Stephanie Fielding (CFO), and Dr. John Martin (CMO) will represent Butterfly Network.

What is the topic of the fireside chat involving Butterfly Network?

The fireside chat will focus on 'Handheld Point-of-Care Ultrasound.'

When is the Butterfly Network fireside chat scheduled?

The fireside chat is scheduled for June 16 at 2:35 p.m. ET.

How can I access the webcast of the Butterfly Network conference session?

The webcast can be accessed via the investor relations section of Butterfly Network's website.

What technology does Butterfly Network use for imaging?

Butterfly Network uses its proprietary Ultrasound-on-Chip™ technology in the Butterfly iQ system.

What is the mission of Butterfly Network?

Butterfly Network aims to democratize medical imaging and contribute to global health equity.